New patent for Novartis drug SCEMBLIX
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers. There are six patents protecting…
Source
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are seventy patents…
Source
Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are seven patents protecting…
Source
Annual Drug Patent Expirations for PARSABIV Parsabiv is a drug marketed by Kai Pharms Inc and is included in one NDA. It is available from one supplier. There are seven…
Source
Annual Drug Patent Expirations for XIGDUO+XR Xigduo Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are five…
Source
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are three patents protecting…
Source
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in two NDAs. It is available from one supplier. There are thirty-three patents protecting…
Source
Annual Drug Patent Expirations for VOXZOGO Voxzogo is a drug marketed by Biomarin Pharm and is included in one NDA. It is available from one supplier. There are four patents…
Source
Annual Drug Patent Expirations for RINVOQ+LQ Rinvoq Lq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. The generic ingredient in…
Source